Aspira Pathlab & Diagnostics share news and announcements
BSE: 540788Healthcare ServicesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹123.45.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹130 Cr3,082nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 23 May 2026
- 10.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −3.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −4.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 23 May 2026
- 0.11
- Volume, BSEVolume. Shares traded on the last trading day.
- 352
Aspira Pathlab & Diagnostics share news and announcements
520 announcements, routine notices left out, newest first. Page 6 of 11.
May 2022
28 May · Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
28 May · Announcement Under Regulation 30 (LODR)-Intimation Of Updated Contact Details Of The Authorised Persons For The Purpose Of Determining The Materiality Of Any Event Or Transaction Or Information.
28 May · Announcement Under Regulation 30 (LODR)-Intimation Of Investment
23 May · Board meeting
Meeting on 28 May 2022: audited results14 May · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
12 May · Intimation Of Receipt Of Request For Reclassification From 'Promoter Group' Category To 'Public' Category.
Apr 2022
21 Apr · Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year March 31, 2022
20 Apr · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
18 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2022
5 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2022
19 Mar · Management
Feb 2022
12 Feb · Board meeting
7 Feb · Board meeting
Meeting on 12 Feb 2022: quarterly results
Jan 2022
10 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....7 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2021
22 Nov · Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligation & Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2021.
13 Nov · Board meeting
13 Nov · Board meeting
8 Nov · Board meeting
Meeting on 13 Nov 2021: quarterly results
Oct 2021
12 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2021
24 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2021
30 Aug · Reg. 34 (1) Annual Report
14 Aug · Board meeting
9 Aug · Board meeting
Meeting on 14 Aug 2021: quarterly results and annual general meeting